1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n- methylmethanamine-ion exchange resin complex, orally disintegrating tablet comprising the same, and method for preparing the same

TW202639518APending Publication Date: 2026-10-01DAEWOONG PHARM CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115107391
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-02-28
Filing Date
2026-03-02
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001079432_001
    Figure TWG2TA001079432_001
  • Figure TWG2TA001079432_002
    Figure TWG2TA001079432_002
  • Figure TWG2TA001079432_003
    Figure TWG2TA001079432_003
Patent Text Reader

Abstract

This invention relates to a 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrole-3-yl)-N-methylmethylamine-ion exchange resin complex with excellent solubility and taste-masking properties, and an oral disintegrating tablet containing the same. The invention relates to a 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl) sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine-ion exchange resin complex having excellent dissolution characteristics and taste-masking property, and an orally disintegrating tablet comprising the same.
Need to check novelty before this filing date? Find Prior Art